Author | Michael B. Atkins, MD | OncLive

Author | Michael B. Atkins, MD

Articles

Dr. Atkins on Long-Term Outcomes of the CheckMate-204 Trial in Melanoma

October 15, 2019

Video

Michael B. Atkins, MD, deputy director, Georgetown-Lombardi Comprehensive Cancer Center, discusses long-term outcomes of the CheckMate-204 trial in melanoma.

Dr. Atkins on CA209-004 Trial Results in Advanced Melanoma

October 03, 2019

Video

Michael B. Atkins, MD, discusses results from the CA209-004 trial, which was a phase I study analyzing patients with advanced, unresectable melanoma treated with nivolumab plus ipilimumab.

Dr. Atkins on Long-Term Survival Benefit of Nivolumab/Ipilimumab in Advanced Melanoma

August 22, 2019

Video

Michael B. Atkins, MD, deputy director, Georgetown-Lombardi Comprehensive Cancer Center, discusses data from a phase I trial exploring the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) in patients with melanoma.

Dr. Atkins Discusses the Adjuvant Treatment of Melanoma

December 08, 2017

Video

Michael B. Atkins, MD, deputy director, Georgetown-Lombardi Comprehensive Cancer Center, professor of oncology and medicine, Georgetown University School of Medicine, discusses the adjuvant treatment of melanoma.

x